ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: The tissue distribution of ANGPTL8 was mainly detected in hepatocytes, and the immunostaining was markedly increased in liver sections obtained from patients with insulin resistance (Figure 2a) and NAFLD (Figure 2b).